LUNGevity's 'Breathe Deep TOGETHER' Campaign Brings Awareness to Lung Cancer Misconceptions
August 13th 2024One of the biggest misconceptions about lung cancer is that it only affects smokers, according to Amy Moore, vice president of Global Engagement and Research Partnerships at LUNGevity.
Read More
FDA Approves Citius Pharmaceuticals’ Lymphir for Cutaneous T-Cell Lymphoma
August 9th 2024In yesterday’s announcement, Citius shared Lymphir is the first and only CTCL therapy specifically targeting the interleukin-2 (IL-2) receptor found on malignant T-cells and regulatory T-cells (Tregs). The drug is also the first FDA-approved product for Citius.
Read More
Exploring Nocturnal Hot Flashes and Poor Sleep in Menopausal Women
August 7th 2024Research in the American Journal of Obstetrics and Gynecology reveals that reducing nighttime hot flashes in menopausal women leads to better sleep quality, fewer nighttime awakenings and increased overall sleep efficiency.
Read More
Today, the clade 2b outbreak has reached alarming proportions, with over 94,000 confirmed cases reported across 117 countries, including significant numbers in the U.S. and Brazil, and up to 103 deaths. The virus has been found to affect younger men who have sex with men, who are linked to high rates of HIV co-infection.
Read More
A Renewed Commitment to HIV Vaccine Development Despite Advancements in Antiretrovirals | AIDS 2024
July 25th 2024The HIV vaccine field has recently faced setbacks with trials like PrepVacc, Mosaico and Imbokodo ending early due to lack of preventive efficacy. Although there have been challenges, scientists have made discoveries showing that the immune system can be prepared to fight HIV with special antibodies.
Read More
Ongoing Stigma Remains a Major Obstacle in the Fight Against HIV | AIDS 2024
July 24th 2024At the 25th annual international AIDS Conference in Munich, Germany, a group of international experts discussed the impact of HIV-related stigma and discrimination on efforts to end the HIV pandemic as a public health threat by 2030.
Read More
Ruxolitinib Cream Proves Safe for Young Children with Atopic Dermatitis
July 22nd 2024These results were found in the TRuE-AD3 study that was presented at the Society for Pediatric Dermatology meeting earlier this month, revealing the latest round of data collected in the TRuE-AD1 and TRuE-AD2 series of studies.
Read More
In this part two interview with Parisi Emami-Naeini from UC Davis Eye Center, she explains that improvements in methods and instruments, faster procedure time and declining reimbursement rates have made pars plana vitrectomy the preferred method for repairing detached retinas, along with reduced training in scleral buckle procedures for new retina specialists.
Read More
Trends in Retinal Detachment Repairs per UC Davis Eye Center Study | ASRS 2024
July 17th 2024The study's results were presented today at the American Society of Retina Specialists meeting in Stockholm, Sweden, by Parisi Emami-Naeini, M.D., M.P.H., a retina specialist at the Tschannen Eye Institute at the UC Davis Eye Center.
Read More
Study Reveals Severe Impact of Atopic Dermatitis on Women's Quality of Life and Reproductive Health
July 15th 2024Although AD is a common condition, it’s impact on sexual function and reproductive health is not well understood. In addition, many women with AD are undertreated during pregnancy due to concerns about medication side effects.
Read More
Ovary Removal Before Menopause is Linked to Cognitive Health Decline
July 10th 2024When women have their ovaries removed before menopause, a procedure known as premenopausal bilateral oophorectomy (PBO), they lose crucial hormones such as estrogen, progesterone and testosterone, which can cause a number of health issues.
Read More